Actelion Receives FDA Approval of Tracleer (bosentan) for Use in Pediatric Patients with Pulmonary Arterial Hypertension

SOUTH SAN FRANCISCO, Calif, September 6, 2017 – Actelion Pharmaceuticals US, Inc., one of the Janssen Pharmaceutical Companies of Johnson& Johnson, announced today that the U.S. Food and Drug Administration (FDA) has approved a new 32 mg...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news